ERBB2 and triple-negative breast carcinoma: The basal-like subtype is for 80% defined as triple-negative breast cancer (TNBC) [7], characterised by the absence of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression.